Biotech founders, scientific communications teams, and investor relations teams use our life sciences pitch deck design service to clarify complex science, organize clinical evidence, and prepare investor presentations for fundraising and partnership discussions.
Fully editable and animated PowerPoint presentations.
Structured to communicate clinical milestones, mechanism of action, and commercialization strategy to investors.
Prepared for Series A, Series B, venture capital meetings, and partnership discussions.

Most life sciences pitch decks contain strong science but lose investor attention before the commercial opportunity becomes clear. These are the most common communication challenges biotech, medtech, and healthcare teams face when preparing for fundraising conversations.
Life sciences fundraising depends on the people who carry the science into the investor room and translate clinical innovation into a case for investment.
For Biotech Founders and Executive TeamsFounders, CEOs, and CSOs preparing for Series A, Series B, and venture capital discussions need a deck that communicates scientific value and commercial opportunity clearly.
We structure the investor presentation around the fundraising stage and the audience in the room
Teams translating platform technologies, clinical innovation, and early-stage science into investor-facing presentations often carry the strongest science and the least investor narrative. We build that narrative from the clinical materials they already have.
Teams responsible for communicating clinical progress, market opportunity, and strategic growth stories to investors and partners need presentation assets that are accurate, clear, and ready for high-stakes discussions. We prepare presentations that hold up to detailed scientific scrutiny.
Pharmaceutical spinouts and research ventures reframing internal scientific programs into external investment opportunities need presentations that speak to commercial investors rather than internal review committees. We restructure existing clinical materials around the fundraising objective.
Editable PowerPoint presentations and supporting assets prepared for life sciences fundraising discussions, partnership meetings, and investor communication.
Presentile combines scientific storytelling and pharma communication design to help healthcare teams present products, data, and medical information more clearly.
Meeting with your team to understand the science, audience, commercialization priorities, and presentation objectives before presentation development begins.
We create three presentation directions based on your scientific communication goals, audience, and commercialization strategy. Once a direction is approved, we develop the presentation using custom visuals prepared for easier reuse and ownership management.
We create three presentation directions based on your scientific communication goals, audience, and commercialization strategy. Once a direction is approved, we develop the presentation using custom visuals prepared for easier reuse, copyright management.
We deliver the completed presentation in fully editable PowerPoint format, prepared for future presentation updates and ongoing investor and partnership communication.
Here you are a list of the questions we frequently hear from our customers
A life sciences pitch deck is an investor presentation built specifically for biotech, medtech, and healthcare companies raising funds or seeking partnerships. It translates complex science, clinical data, and development timelines into a clear commercial case that investors can evaluate and act on.
We only work with our in-house medically graduated team. Because we sign an NDA before any materials are shared, we never pass your science or clinical data to freelancers.
The scientific content is structured around the commercial opportunity, not presented in parallel to it. Clinical data, mechanism of action, and platform differentiation are built to support the investment case at each stage of the presentation. Investors follow the science more confidently when the commercial logic is visible throughout rather than introduced only at the end of the presentation.
The presentation is built with a clear information hierarchy. Scientific credibility is established early through evidence quality, clinical data presentation, and development stage clarity. The commercial logic is then layered progressively so investors can follow the opportunity without working through dense clinical context first.
Yes. We sign an NDA before any materials are shared with us. No scientific data, clinical findings, or fundraising documents are reviewed until the agreement
Yes. Because all files are delivered in fully editable PowerPoint format, the core presentation can be adapted for seed investors, venture capital audiences, pharmaceutical partners, and licensing discussions without rebuilding from scratch for every discussion. The commercial logic, milestone emphasis, and market opportunity framing are adjusted for each specific audience.
Both. We can restructure an existing presentation around a stronger investor narrative, or build from your raw scientific and clinical materials if nothing exists yet. Either way, the starting point is the science rather than a blank slide.
Yes. We design across the full range of life sciences communication needs including medical affairs presentations, KOL and speaker presentations, scientific congress posters, disease awareness materials, medical training presentations, product training presentations, and corporate communications. Each service follows the same in-house production process and is covered by NDA before any materials are shared.
We work exclusively within life sciences, biotech, medtech, diagnostics, and healthcare. Our designers are medically graduated and our team brings over 20 years of experience working with life sciences organisations, so every project is handled by people who understand the science from the inside, not designers applying a visual layer from the outside.
AI tools can produce slides quickly but cannot validate clinical data, structure an investment case around a specific development stage, or adapt the commercial narrative to a particular investor audience. A pitch deck built without scientific and commercial oversight carries real credibility risk in a fundraising meeting. Every presentation we build is developed specifically for the science, the fundraising stage, and the investor audience being addressed.